CTC Count Can Predict Outcome in Prostate Cancer

(MedPage Today) -- Baseline circulating tumor cell (CTC) count was found to be significantly predictive of clinical outcome in a phase III trial of metastatic castration-sensitive prostate cancer (mCSPC) presented at the 2020 American Society of...